These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38270925)

  • 21. Clinical utility of genetic diagnosis for sporadic and hereditary medullary thyroid carcinoma.
    Elisei R; Bottici V; Cappagli V; Ramone T; Tacito A; Ciampi R; Romei C
    Ann Endocrinol (Paris); 2019 Jun; 80(3):187-190. PubMed ID: 31053251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extension of Prophylactic Surgery in Medullary Thyroid Carcinoma. Differences Between Sporadic and Hereditary Tumours According to Calcitonin Levels and Lymph Node Involvement.
    Juez LD; Mercader E; Amunategui I; Febrero B; Rodríguez JM; Gómez-Ramírez J;
    World J Surg; 2022 Apr; 46(4):820-828. PubMed ID: 35089388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Surgical management of medullary thyroid carcinoma. Personal experience].
    Geraci G; Pisello F; Tornambè A; Platia L; Sciumè C; Li Volsi F; Cupido F; Modica G
    G Chir; 2007 Oct; 28(10):385-9. PubMed ID: 17915054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current understanding and management of medullary thyroid cancer.
    Roy M; Chen H; Sippel RS
    Oncologist; 2013; 18(10):1093-100. PubMed ID: 24037980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prophylactic thyroidectomy in children who are carriers of a multiple endocrine neoplasia type 2 mutation: description of 20 cases and recommendations based on the literature].
    de Groot JW; Links TP; Rouwe CW; van der Wal JE; Hofstra RM; Plukker JT
    Ned Tijdschr Geneeskd; 2006 Feb; 150(6):311-8. PubMed ID: 16503023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medullary Thyroid Cancer: Single Institute Experience Over 3 Decades and Risk Factors for Recurrence.
    Abou Azar S; Tobias J; Applewhite M; Angelos P; Keutgen XM
    J Clin Endocrinol Metab; 2024 Oct; 109(11):2729-2734. PubMed ID: 38651609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients.
    Pelizzo MR; Boschin IM; Bernante P; Toniato A; Piotto A; Pagetta C; Nibale O; Rampin L; Muzzio PC; Rubello D
    Eur J Surg Oncol; 2007 May; 33(4):493-7. PubMed ID: 17125960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oncological features of sporadic vs. hereditary pediatric medullary thyroid cancer.
    Machens A; Lorenz K; Weber F; Dralle H
    Endocrine; 2024 Sep; 85(3):1091-1095. PubMed ID: 39003661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complete surgical lymph node resection does not prevent authentic recurrences of medullary thyroid carcinoma.
    Franc S; Niccoli-Sire P; Cohen R; Bardet S; Maes B; Murat A; Krivitzky A; Modigliani E;
    Clin Endocrinol (Oxf); 2001 Sep; 55(3):403-9. PubMed ID: 11589685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical review: Incidentally discovered medullary thyroid cancer: diagnostic strategies and treatment.
    Ahmed SR; Ball DW
    J Clin Endocrinol Metab; 2011 May; 96(5):1237-45. PubMed ID: 21346073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medullary thyroid carcinoma in children with multiple endocrine neoplasia types 2A and 2B.
    Skinner MA; DeBenedetti MK; Moley JF; Norton JA; Wells SA
    J Pediatr Surg; 1996 Jan; 31(1):177-81; discussion 181-2. PubMed ID: 8632274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alternative surgical strategies and favorable outcomes in patients with medullary thyroid carcinoma in Japan: experience of a single institution.
    Ito Y; Miyauchi A; Yabuta T; Fukushima M; Inoue H; Tomoda C; Uruno T; Kihara M; Higashiyama T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F
    World J Surg; 2009 Jan; 33(1):58-66. PubMed ID: 19005720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence by age and predictors of medullary thyroid cancer in patients with lower risk germline RET proto-oncogene mutations.
    Rich TA; Feng L; Busaidy N; Cote GJ; Gagel RF; Hu M; Jimenez C; Lee JE; Perrier N; Sherman SI; Waguespack SG; Ying A; Grubbs E
    Thyroid; 2014 Jul; 24(7):1096-106. PubMed ID: 24617864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preoperative basal calcitonin and tumor stage correlate with postoperative calcitonin normalization in patients undergoing initial surgical management of medullary thyroid carcinoma.
    Yip DT; Hassan M; Pazaitou-Panayiotou K; Ruan DT; Gawande AA; Gaz RD; Moore FD; Hodin RA; Stephen AE; Sadow PM; Daniels GH; Randolph GW; Parangi S; Lubitz CC
    Surgery; 2011 Dec; 150(6):1168-77. PubMed ID: 22136837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term outcome of prophylactic thyroidectomy in children carrying RET germline mutations.
    Machens A; Elwerr M; Lorenz K; Weber F; Dralle H
    Br J Surg; 2018 Jan; 105(2):e150-e157. PubMed ID: 29341155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d'Etudes des Tumeurs a Calcitonine (GETC).
    Cohen R; Campos JM; Salaün C; Heshmati HM; Kraimps JL; Proye C; Sarfati E; Henry JF; Niccoli-Sire P; Modigliani E
    J Clin Endocrinol Metab; 2000 Feb; 85(2):919-22. PubMed ID: 10690910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anatomical Patterns of Nodal Spread in Unilateral Papillary and Medullary Thyroid Cancer.
    Machens A; Lorenz K; Weber F; Dralle H
    Thyroid; 2024 Jul; 34(7):871-879. PubMed ID: 38717955
    [No Abstract]   [Full Text] [Related]  

  • 38. Timing and extent of thyroid surgery for gene carriers of hereditary C cell disease--a consensus statement of the European Society of Endocrine Surgeons (ESES).
    Niederle B; Sebag F; Brauckhoff M
    Langenbecks Arch Surg; 2014 Feb; 399(2):185-97. PubMed ID: 24297502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical diagnosis and treatment of familial medullary thyroid carcinoma caused by a p.C618Y RET proto-oncogene mutation in a Chinese pedigree].
    Zhao JQ; Guo L; Qi XP; Chen ZG; Wang KJ; Lou JL; Yu XH; Cheng J; Jin HY; Li XL; Ying RB; Zhang XN
    Zhonghua Yi Xue Za Zhi; 2013 Feb; 93(6):440-4. PubMed ID: 23660264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of modified radical neck dissection on biochemical cure in medullary thyroid carcinomas.
    Weber T; Schilling T; Frank-Raue K; Colombo-Benkmann M; Hinz U; Ziegler R; Klar E
    Surgery; 2001 Dec; 130(6):1044-9. PubMed ID: 11742336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.